Alfresa Holdings Corporation

Tokyo Stock Exchange 2784.T

Alfresa Holdings Corporation Return on Equity (ROE) for the year ending March 31, 2024: 6.16%

Alfresa Holdings Corporation Return on Equity (ROE) is 6.16% for the year ending March 31, 2024, a 16.66% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Alfresa Holdings Corporation Return on Equity (ROE) for the year ending March 31, 2023 was 5.28%, a -22.58% change year over year.
Alfresa Holdings Corporation Return on Equity (ROE) for the year ending March 31, 2022 was 6.82%, a 36.40% change year over year.
Alfresa Holdings Corporation Return on Equity (ROE) for the year ending March 31, 2021 was 5.00%, a -41.15% change year over year.
Alfresa Holdings Corporation Return on Equity (ROE) for the year ending March 31, 2020 was 8.50%, a -10.11% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

Tokyo Stock Exchange: 2784.T

Alfresa Holdings Corporation

CEO	Mr. Ryuji Arakawa
IPO Date	Sept. 29, 2005
Location	Japan
Headquarters	1-1-3 Otemachi
Employees	12,517
Sector	Healthcare
Industries Pharmaceuticals Automotive Parts Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care

Description

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.

Key trends

Past 5 years